Systemic anticancer therapy service redesign
Intended for healthcare professionals
Evidence and practice    

Systemic anticancer therapy service redesign

Caroline Rennie Macmillan nurse consultant, cancer services, NHS Ayrshire and Arran, Kilmarnock, Scotland
Nicky Batty Macmillan practice development facilitator, cancer services, NHS Ayrshire and Arran, Kilmarnock, Scotland

Why you should read this article:
  • To better understand the implications of the growing demand for systemic anticancer therapy (SACT)

  • To read about the Future Service Delivery model project for SACT services in the West of Scotland

  • To learn how interim changes made to SACT services during COVID-19, aligned to the Future Service Deliver model, have been embedded in one West of Scotland health board

Demand for systemic anticancer therapy (SACT) has grown in recent years. To meet this rising demand, the West of Scotland Cancer Network (WoSCAN) initiated a regional two-phase project in 2015 to develop a safe and sustainable SACT service delivery model. NHS Ayrshire and Arran, one of four health boards in the West of Scotland, implemented some of the phase-1 initiatives in its SACT services before the coronavirus disease 2019 pandemic. This provided the groundwork for the rapid reconfiguration of SACT services that was required during the pandemic.

The reconfiguration was aligned with the WoSCAN service delivery model, which has supported sustainability of the changes. This article gives an overview of the WoSCAN Future Service Delivery model project, some of the initiatives implemented by NHS Ayrshire and Arran before the pandemic and some elements of the interim service redesign undertaken during the pandemic that remain in place.

Cancer Nursing Practice. doi: 10.7748/cnp.2024.e1849

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Correspondence

caroline.rennie@aapct.scot.nhs.uk

Conflict of interest

None declared

Rennie C, Batty N (2024) Systemic anticancer therapy service redesign. Cancer Nursing Practice. doi: 10.7748/cnp.2024.e1849

Published online: 19 March 2024

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more